{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:48:48Z","timestamp":1787240928701,"version":"build-2736575974"},"reference-count":208,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nontuberculous mycobacteria (NTM) are ubiquitous in the environment and 193 species of NTM have been discovered thus far. NTM species vary in virulence from benign environmental organisms to difficult-to-treat human pathogens. Pulmonary infections remain the most common manifestation of NTM disease in humans and bronchiectasis continues to be a major risk factor for NTM pulmonary disease (NTM PD). This article will provide a useful introduction and framework for clinicians involved in the management of bronchiectasis and NTM. It includes an overview of the epidemiology, pathogenesis, diagnosis, and management of NTM PD. We will address the challenges faced in the diagnosis of NTM PD and the importance of subspeciation in guiding treatment and follow-up, especially in Mycobacterium abscessus infections. The treatment of both Mycobacterium avium complex and M. abscessus, the two most common NTM species known to cause disease, will be discussed in detail. Elements of the recent ATS\/ERS\/ESCMID\/IDSA NTM guidelines published in 2020 will also be reviewed.<\/jats:p>","DOI":"10.1055\/s-0041-1730997","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T18:34:05Z","timestamp":1626287645000},"page":"567-586","source":"Crossref","is-referenced-by-count":15,"title":["Nontuberculous Mycobacteria"],"prefix":"10.1055","volume":"42","author":[{"given":"Shera","family":"Tan","sequence":"additional","affiliation":[{"name":"Tuberculosis Control Unit, Tan Tock Seng Hospital, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Kasperbauer","sequence":"additional","affiliation":[{"name":"Division of Mycobacterial and Respiratory Infections, National Jewish Health, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2021,7,14]]},"reference":[{"issue":"06","key":"ref1","first-page":"1032","article-title":"Mycobacteria in soil and their relation to disease-associated strains","volume":"97","author":"E Wolinsky","year":"1968","journal-title":"Am Rev Respir Dis"},{"issue":"03","key":"ref2","first-page":"287","article-title":"Water as a source of potentially pathogenic mycobacteria","volume":"113","author":"S Goslee","year":"1976","journal-title":"Am Rev Respir Dis"},{"issue":"06","key":"ref3","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2217\/fmb.10.53","article-title":"Impact of human activities on the ecology of nontuberculous mycobacteria","volume":"5","author":"J O Falkinham","year":"2010","journal-title":"Future Microbiol"},{"issue":"06","key":"ref4","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3201\/eid0706.010623","article-title":"Nontuberculous mycobacterial disease following hot tub exposure","volume":"7","author":"E J Mangione","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"01","key":"ref6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0033-1333568","article-title":"Ecology of nontuberculous mycobacteria--where do human infections come from?","volume":"34","author":"J O Falkinham III","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"issue":"06","key":"ref7","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1128\/JCM.00186-13","article-title":"Absence of Mycobacterium intracellulare and presence of Mycobacterium chimaera in household water and biofilm samples of patients in the United States with Mycobacterium avium complex respiratory disease","volume":"51","author":"R J Wallace Jr","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"03","key":"ref8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3201\/eid1703.101510","article-title":"Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease","volume":"17","author":"J O Falkinham III","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"38","key":"ref9","doi-asserted-by":"crossref","first-page":"16393","DOI":"10.1073\/pnas.0908446106","article-title":"Opportunistic pathogens enriched in showerhead biofilms","volume":"106","author":"L M Feazel","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1469-0691.2009.03014.x","article-title":"Clinical manifestations of nontuberculous mycobacteria infections","volume":"15","author":"E Tortoli","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.bi.64.070195.000333","article-title":"The envelope of mycobacteria","volume":"64","author":"P J Brennan","year":"1995","journal-title":"Annu Rev Biochem"},{"issue":"02","key":"ref12","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1365-2672.2009.04161.x","article-title":"Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment","volume":"107","author":"J O Falkinham III","year":"2009","journal-title":"J Appl Microbiol"},{"issue":"01","key":"ref13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0025-7125(16)34193-1","article-title":"Anonymous mycobacteria in pulmonary disease","volume":"43","author":"E H Runyon","year":"1959","journal-title":"Med Clin North Am"},{"issue":"05","key":"ref14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3343\/alm.2013.33.5.349","article-title":"The combination of real-time PCR and HPLC for the identification of non-tuberculous mycobacteria","volume":"33","author":"J S Park","year":"2013","journal-title":"Ann Lab Med"},{"issue":"02","key":"ref15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1128\/jcm.34.2.296-303.1996","article-title":"Two-laboratory collaborative study on identification of mycobacteria: molecular versus phenotypic methods","volume":"34","author":"B Springer","year":"1996","journal-title":"J Clin Microbiol"},{"issue":"07","key":"ref16","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1128\/JCM.00233-14","article-title":"Utility of rpoB gene sequencing for identification of nontuberculous mycobacteria in the Netherlands","volume":"52","author":"R de Zwaan","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"01","key":"ref17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1128\/JCM.36.1.139-147.1998","article-title":"Differentiation of phylogenetically related slowly growing mycobacteria based on 16S-23S rRNA gene internal transcribed spacer sequences","volume":"36","author":"A Roth","year":"1998","journal-title":"J Clin Microbiol"},{"issue":"07","key":"ref18","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1128\/JCM.42.7.3000-3011.2004","article-title":"Assessment of partial sequencing of the 65-kilodalton heat shock protein gene (hsp65) for routine identification of Mycobacterium species isolated from clinical sources","volume":"42","author":"A McNabb","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1128\/JCM.41.12.5699-5708.2003","article-title":"rpoB-based identification of nonpigmented and late-pigmenting rapidly growing mycobacteria","volume":"41","author":"T Ad\u00e9kambi","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"01","key":"ref20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ccm.2014.11.005","article-title":"Microbiological diagnosis of nontuberculous mycobacterial pulmonary disease","volume":"36","author":"Jakko van Ingen","year":"2015","journal-title":"Clin Chest Med"},{"issue":"02","key":"ref21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/JCM.01274-10","article-title":"Multilocus sequence analysis and rpoB sequencing of Mycobacterium abscessus (sensu lato) strains","volume":"49","author":"E Macheras","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"07","key":"ref22","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1128\/JCM.01688-08","article-title":"Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii","volume":"47","author":"A M Zelazny","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"03","key":"ref23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1164\/rccm.201003-0395OC","article-title":"Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus","volume":"183","author":"W J Koh","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"05","key":"ref25","first-page":"1007","article-title":"The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey","volume":"135","author":"R J O'Brien","year":"1987","journal-title":"Am Rev Respir Dis"},{"issue":"01","key":"ref26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1513\/AnnalsATS.201607-573OC","article-title":"A laboratory-based analysis of nontuberculous mycobacterial lung disease in Japan from 2012 to 2013","volume":"14","author":"K Morimoto","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"08","key":"ref27","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1164\/rccm.201111-2016OC","article-title":"Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries","volume":"185","author":"J Adjemian","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"04","key":"ref28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"D E Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"07","key":"ref29","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1164\/rccm.201003-0503OC","article-title":"Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease","volume":"182","author":"K L Winthrop","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"07","key":"ref30","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1164\/rccm.201002-0310OC","article-title":"Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems","volume":"182","author":"D R Prevots","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"ref31","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.3201\/eid1911.130737","article-title":"Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010","volume":"19","author":"T K Marras","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"08","key":"ref32","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/thx.2006.070797","article-title":"Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003","volume":"62","author":"T K Marras","year":"2007","journal-title":"Thorax"},{"issue":"01","key":"ref33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1155\/2011\/865831","article-title":"Isolation prevalence of pulmonary nontuberculous mycobacteria in Ontario in 2007","volume":"18","author":"M Al Houqani","year":"2011","journal-title":"Can Respir J"},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1590\/S1806-37132008001100010","article-title":"Nontuberculous mycobacteria isolated in S\u00e3o Jos\u00e9 do Rio Preto, Brazil between 1996 and 2005","volume":"34","author":"HdaS Pedro","year":"2008","journal-title":"J Bras Pneumol"},{"issue":"08","key":"ref35","first-page":"590","article-title":"Descriptive study of the frequency of nontuberculous mycobacteria in the Baixada Santista region of the state of S\u00e3o Paulo, Brazil","volume":"34","author":"L A Zamarioli","year":"2008","journal-title":"J Bras Pneumol"},{"issue":"01","key":"ref36","first-page":"3","article-title":"Disease caused by non-tuberculous mycobacteria: diagnostic procedures and treatment evaluation in the North of Buenos Aires Province","volume":"44","author":"B Imperiale","year":"2012","journal-title":"Rev Argent Microbiol"},{"issue":"03","key":"ref37","first-page":"393","article-title":"Clinical and therapeutic features of pulmonary nontuberculous mycobacterial disease, Brazil, 1993-2011","volume":"19","author":"K G de Mello","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"07","key":"ref38","doi-asserted-by":"crossref","first-page":"e2340","DOI":"10.1371\/journal.pntd.0002340","article-title":"Occurrence of nontuberculous mycobacterial pulmonary infection in an endemic area of tuberculosis","volume":"7","author":"A R Fusco da Costa","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"06","key":"ref39","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1183\/09031936.00063806","article-title":"Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients","volume":"28","author":"M Dailloux","year":"2006","journal-title":"Eur Respir J"},{"issue":"05","key":"ref40","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1183\/09031936.04.00114004","article-title":"Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response","volume":"23","author":"M T Henry","year":"2004","journal-title":"Eur Respir J"},{"issue":"06","key":"ref41","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/thx.2008.110957","article-title":"Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, the Netherlands","volume":"64","author":"J van Ingen","year":"2009","journal-title":"Thorax"},{"issue":"03","key":"ref42","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/rmed.2003.1431","article-title":"Nontuberculous mycobacteria: incidence in Southwest Ireland from 1987 to 2000","volume":"97","author":"M P Kennedy","year":"2003","journal-title":"Respir Med"},{"issue":"07","key":"ref43","first-page":"807","article-title":"Epidemiology and clinical significance of mycobacterial respiratory infections in Central Greece","volume":"12","author":"I Gerogianni","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"issue":"06","key":"ref44","doi-asserted-by":"crossref","first-page":"836","DOI":"10.5588\/ijtld.12.0843","article-title":"Geographical distribution and clinical relevance of non-tuberculous mycobacteria in Croatia","volume":"17","author":"M Jankovic","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"issue":"02","key":"ref45","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jinf.2009.01.001","article-title":"Mycobacterium xenopi pulmonary disease - epidemiology and clinical features in non-immunocompromised patients","volume":"58","author":"A Marusi\u0107","year":"2009","journal-title":"J Infect"},{"issue":"01","key":"ref46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ccm.2014.10.002","article-title":"Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review","volume":"36","author":"R D Prevots","year":"2015","journal-title":"Clin Chest Med"},{"issue":"05","key":"ref47","doi-asserted-by":"crossref","first-page":"e63170","DOI":"10.1371\/journal.pone.0063170","article-title":"Prevalence of non-tuberculous mycobacterial infections among tuberculosis suspects in Nigeria","volume":"8","author":"G Aliyu","year":"2013","journal-title":"PLoS One"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2334-13-88","article-title":"Species and genotypic diversity of non-tuberculous mycobacteria isolated from children investigated for pulmonary tuberculosis in rural Uganda","volume":"13","author":"B B Asiimwe","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"05","key":"ref49","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1183\/09031936.00144710","article-title":"Failing a re-treatment regimen does not predict MDR\/XDR tuberculosis: is \u201cblind\u201d treatment dangerous?","volume":"37","author":"G Badoum","year":"2011","journal-title":"Eur Respir J"},{"issue":"04","key":"ref50","first-page":"399","article-title":"Nontuberculous mycobacteria isolated from pulmonary specimens between 2004 and 2009: causative agent or not?","volume":"33","author":"C Bicmen","year":"2010","journal-title":"New Microbiol"},{"issue":"05","key":"ref51","doi-asserted-by":"crossref","first-page":"e2234","DOI":"10.1371\/journal.pntd.0002234","article-title":"Emergence of clinically relevant non-tuberculous mycobacterial infections in Saudi Arabia","volume":"7","author":"B Varghese","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"02","key":"ref52","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3201\/eid1502.080977","article-title":"Clinical relevance of nontuberculous mycobacteria, Oman","volume":"15","author":"S H Al-Mahruqi","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"02","key":"ref53","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1378\/chest.129.2.341","article-title":"Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea","volume":"129","author":"W J Koh","year":"2006","journal-title":"Chest"},{"issue":"08","key":"ref54","first-page":"1069","article-title":"Rapid increase of non-tuberculous mycobacterial lung diseases at a tertiary referral hospital in South Korea","volume":"14","author":"Y S Park","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"ref55","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3109\/00365548.2012.681695","article-title":"Changing epidemiology of nontuberculous mycobacterial lung disease in South Korea","volume":"44","author":"S K Lee","year":"2012","journal-title":"Scand J Infect Dis"},{"issue":"16","key":"ref56","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.2169\/internalmedicine.47.1114","article-title":"Clinical factors on cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease","volume":"47","author":"M Okumura","year":"2008","journal-title":"Intern Med"},{"issue":"05","key":"ref57","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1164\/rccm.201107-1203OC","article-title":"Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease","volume":"185","author":"M Hayashi","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"05","key":"ref58","first-page":"499","article-title":"Nontuberculous mycobacterial lung disease in southern Taiwan","volume":"32","author":"C C Wang","year":"2009","journal-title":"Chang Gung Med J"},{"issue":"06","key":"ref59","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00408-011-9321-4","article-title":"Clinical characteristics and prognosis of nontuberculous mycobacterial lung disease with different radiographic patterns","volume":"189","author":"C C Shu","year":"2011","journal-title":"Lung"},{"issue":"02","key":"ref60","first-page":"180","article-title":"National atypical mycobacteria survey, 2000","volume":"27","author":"F Haverkort","year":"2003","journal-title":"Commun Dis Intell Q Rep"},{"key":"ref61","first-page":"U2580","article-title":"Incidence of nontuberculous mycobacterial disease in New Zealand, 2004","volume":"120","author":"J Freeman","year":"2007","journal-title":"N Z Med J"},{"issue":"10","key":"ref62","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.3201\/eid1610.091201","article-title":"Changing epidemiology of pulmonary nontuberculous mycobacteria infections","volume":"16","author":"R M Thomson","year":"2010","journal-title":"Emerg Infect Dis"},{"issue":"01","key":"ref63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ccm.2014.10.003","article-title":"Environmental sources of nontuberculous mycobacteria","volume":"36","author":"J O Falkinham III","year":"2015","journal-title":"Clin Chest Med"},{"issue":"06","key":"ref64","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1128\/AEM.02573-05","article-title":"Effect of growth in biofilms on chlorine susceptibility of Mycobacterium avium and Mycobacterium intracellulare","volume":"72","author":"K A Steed","year":"2006","journal-title":"Appl Environ Microbiol"},{"issue":"01","key":"ref65","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1574-6968.2000.tb08871.x","article-title":"Mycobacterium avium resists exposure to the acidic conditions of the stomach","volume":"182","author":"T Bodmer","year":"2000","journal-title":"FEMS Microbiol Lett"},{"issue":"02","key":"ref66","first-page":"213","article-title":"Growth of mycobacteria in relation to the pH of the medium","volume":"133","author":"F Portaels","year":"1982","journal-title":"Ann Microbiol (Paris)"},{"issue":"06","key":"ref67","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1128\/aem.58.6.1869-1873.1992","article-title":"Heat susceptibility of aquatic mycobacteria","volume":"58","author":"R Schulze-R\u00f6bbecke","year":"1992","journal-title":"Appl Environ Microbiol"},{"issue":"04","key":"ref68","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1128\/AEM.66.4.1702-1705.2000","article-title":"Chlorine, chloramine, chlorine dioxide, and ozone susceptibility of Mycobacterium avium","volume":"66","author":"R H Taylor","year":"2000","journal-title":"Appl Environ Microbiol"},{"issue":"06","key":"ref69","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.watres.2003.07.008","article-title":"Survival of Mycobacterium avium in a model distribution system","volume":"38","author":"C D Norton","year":"2004","journal-title":"Water Res"},{"issue":"04","key":"ref70","first-page":"652","article-title":"Epidemiology of infection by nontuberculous mycobacteria. IV. Preferential aerosolization of Mycobacterium intracellulare from natural waters","volume":"128","author":"B C Parker","year":"1983","journal-title":"Am Rev Respir Dis"},{"issue":"09","key":"ref71","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1080\/00365540903089468","article-title":"Mycobacterial infections in coal workers' pneumoconiosis patients in South Korea","volume":"41","author":"Y M Kim","year":"2009","journal-title":"Scand J Infect Dis"},{"issue":"02","key":"ref72","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1378\/chest.75.2.115","article-title":"Pulmonary mycobacterial infections due to Mycobacterium intracellulare-avium complex. Clinical features and course in 100 consecutive cases","volume":"75","author":"D Y Rosenzweig","year":"1979","journal-title":"Chest"},{"issue":"08","key":"ref73","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1080\/00365540701225744","article-title":"Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages","volume":"39","author":"E D Chan","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1164\/rccm.200303-365OC","article-title":"Primary ciliary dyskinesia. Diagnostic and phenotypic features","volume":"169","author":"P G Noone","year":"2004","journal-title":"Am J Respir Crit Care"},{"issue":"02","key":"ref75","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00005792-199403000-00003","article-title":"Isolation of mycobacteria in patients with pulmonary alveolar proteinosis","volume":"73","author":"L A Witty","year":"1994","journal-title":"Medicine (Baltimore)"},{"issue":"13","key":"ref76","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1056\/NEJM198909283211304","article-title":"Infection with Mycobacterium avium complex in patients without predisposing conditions","volume":"321","author":"D S Prince","year":"1989","journal-title":"N Engl J Med"},{"issue":"01","key":"ref77","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.genm.2010.01.005","article-title":"Slender, older women appear to be more susceptible to nontuberculous mycobacterial lung disease","volume":"7","author":"E D Chan","year":"2010","journal-title":"Gend Med"},{"issue":"04","key":"ref78","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1164\/ajrccm\/144.4.914","article-title":"Pectus excavatum and scoliosis. Thoracic anomalies associated with pulmonary disease caused by Mycobacterium avium complex","volume":"144","author":"M D Iseman","year":"1991","journal-title":"Am Rev Respir Dis"},{"issue":"10","key":"ref79","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1164\/rccm.200805-686OC","article-title":"Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome","volume":"178","author":"R D Kim","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"06","key":"ref80","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1378\/chest.101.6.1605","article-title":"Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The Lady Windermere syndrome","volume":"101","author":"J M Reich","year":"1992","journal-title":"Chest"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/29795","article-title":"Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression","volume":"394","author":"G M Lord","year":"1998","journal-title":"Nature"},{"issue":"02","key":"ref82","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1164\/rccm.201206-1035OC","article-title":"Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes","volume":"187","author":"M Kartalija","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(05)67789-6","article-title":"Marfan's syndrome","volume":"366","author":"D P Judge","year":"2005","journal-title":"Lancet"},{"issue":"04","key":"ref84","first-page":"549","article-title":"Production of TNF-\u03b1, IL-6 and TGF-\u03b2, and expression of receptors for TNF-\u03b1 and IL-6, during murine Mycobacterium avium infection","volume":"84","author":"J Champsi","year":"1995","journal-title":"Immunology"},{"issue":"05","key":"ref85","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0882-4010(91)90022-3","article-title":"Transforming growth factor beta (TGF-b1) plays a detrimental role in the progression of experimental Mycobacterium avium infection; in vivo and in vitro evidence","volume":"11","author":"M Denis","year":"1991","journal-title":"Microb Pathog"},{"issue":"04","key":"ref86","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1378\/chest.06-1906","article-title":"Gastroesophageal reflux disease, acid suppression, and Mycobacterium avium complex pulmonary disease","volume":"131","author":"R M Thomson","year":"2007","journal-title":"Chest"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"46546","DOI":"10.1038\/srep46546","article-title":"Nontuberculous mycobacteria in gastrostomy fed patients with cystic fibrosis","volume":"7","author":"H Al-Momani","year":"2017","journal-title":"Sci Rep"},{"issue":"03","key":"ref88","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1164\/rccm.202001-0011LE","article-title":"Mycobacterium abscessus and gastroesophageal reflux: an in vitro study","volume":"202","author":"S N Dawrs","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"06","key":"ref89","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1378\/chest.06-2280","article-title":"Prevalence of gastroesophageal reflux disease in patients with nontuberculous mycobacterial lung disease","volume":"131","author":"W J Koh","year":"2007","journal-title":"Chest"},{"issue":"01","key":"ref90","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1440-1843.2011.02076.x","article-title":"Increased risk of nontuberculous mycobacterial infection in asthmatic patients using long-term inhaled corticosteroid therapy","volume":"17","author":"M Hojo","year":"2012","journal-title":"Respirology"},{"issue":"03","key":"ref91","doi-asserted-by":"crossref","first-page":"1700037","DOI":"10.1183\/13993003.00037-2017","article-title":"The risk of mycobacterial infections associated with inhaled corticosteroid use","volume":"50","author":"S K Brode","year":"2017","journal-title":"Eur Respir J"},{"issue":"01","key":"ref92","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/annrheumdis-2011-200690","article-title":"Mycobacterial diseases and antitumour necrosis factor therapy in USA","volume":"72","author":"K L Winthrop","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"03","key":"ref93","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1183\/09031936.99.13353599","article-title":"Pathological and radiological changes in resected lung specimens in Mycobacterium avium intracellulare complex disease","volume":"13","author":"J Fujita","year":"1999","journal-title":"Eur Respir J"},{"issue":"02","key":"ref94","doi-asserted-by":"crossref","first-page":"e57402","DOI":"10.1371\/journal.pone.0057402","article-title":"Mycobacterium abscessus induces a limited pattern of neutrophil activation that promotes pathogen survival","volume":"8","author":"K C Malcolm","year":"2013","journal-title":"PLoS One"},{"issue":"01","key":"ref95","doi-asserted-by":"crossref","first-page":"200535","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"C L Daley","year":"2020","journal-title":"Eur Respir J"},{"issue":"03","key":"ref96","doi-asserted-by":"crossref","first-page":"1600537","DOI":"10.1183\/13993003.00537-2016","article-title":"Natural history of Mycobacterium avium complex lung disease in untreated patients with stable course","volume":"49","author":"J A Hwang","year":"2017","journal-title":"Eur Respir J"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2019.03.014","article-title":"Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease","volume":"151","author":"S M Moon","year":"2019","journal-title":"Respir Med"},{"issue":"07","key":"ref98","first-page":"814","article-title":"Better patient instruction for sputum sampling can improve microscopic tuberculosis diagnosis","volume":"9","author":"B Alisjahbana","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"issue":"03","key":"ref99","first-page":"272","article-title":"Viability of stored sputum specimens for smear microscopy and culture","volume":"4","author":"H T Banda","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"issue":"03","key":"ref100","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1378\/chest.99.3.667","article-title":"Diagnosis of disease caused by Mycobacterium avium complex","volume":"99","author":"M Tsukamura","year":"1991","journal-title":"Chest"},{"issue":"01","key":"ref101","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1378\/chest.120.1.250","article-title":"Lessons from a proficiency testing event for acid-fast microscopy","volume":"120","author":"A Somosk\u00f6vi","year":"2001","journal-title":"Chest"},{"issue":"05","key":"ref102","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1128\/JCM.42.5.2321-2325.2004","article-title":"Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria","volume":"42","author":"M Cruciani","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"01","key":"ref103","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0732-8893(99)00014-0","article-title":"Blood and charcoal added to acidified agar media promote the growth of Mycobacterium genavense","volume":"34","author":"L Realini","year":"1999","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"04","key":"ref104","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1128\/CMR.9.4.435","article-title":"Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans","volume":"9","author":"M A Saubolle","year":"1996","journal-title":"Clin Microbiol Rev"},{"issue":"08","key":"ref105","first-page":"e00516","article-title":"GenoType NTM-DR performance evaluation for identification of Mycobacterium avium complex and Mycobacterium abscessus and determination of clarithromycin and amikacin resistance","volume":"57","author":"H J Huh","year":"2019","journal-title":"J Clin Microbiol"},{"key":"ref106","volume-title":"Performance Standards for Susceptibility Testing of Mycobacteria, Nocardia spp, and Other Aerobic Actinomycetes","author":"CLSI","year":"2018"},{"key":"ref107","volume-title":"Susceptibility Testing of Mycobacteria, Nocardia spp, and Other Aerobic Actinomycetes","author":"CLSI","year":"2018"},{"issue":"05","key":"ref108","first-page":"CD008351","article-title":"Airway clearance techniques for bronchiectasis","author":"A L Lee","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"S 01","key":"ref109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/thoraxjnl-2018-212463","article-title":"British Thoracic Society Guideline for bronchiectasis in adults","volume":"74","author":"A T Hill","year":"2019","journal-title":"Thorax"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2466-13-21","article-title":"Effectiveness of treatment with high-frequency chest wall oscillation in patients with bronchiectasis","volume":"13","author":"A Nicolini","year":"2013","journal-title":"BMC Pulm Med"},{"issue":"10","key":"ref111","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1136\/thx.52.10.900","article-title":"Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis","volume":"52","author":"M Robinson","year":"1997","journal-title":"Thorax"},{"issue":"03","key":"ref112","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ajg.2012.444","article-title":"Guidelines for the diagnosis and management of gastroesophageal reflux disease","volume":"108","author":"P O Katz","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"02","key":"ref113","first-page":"104","article-title":"Abnormal lower esophageal sphincter pressure responses in patients with orange juice-induced heartburn","volume":"81","author":"J P Cranley","year":"1986","journal-title":"Am J Gastroenterol"},{"issue":"01","key":"ref114","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0016-5085(95)90016-0","article-title":"Relationships between the acidity and osmolality of popular beverages and reported postprandial heartburn","volume":"108","author":"M Feldman","year":"1995","journal-title":"Gastroenterology"},{"issue":"11","key":"ref115","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/00042737-199911000-00015","article-title":"Effect of coffee on gastro-oesophageal reflux in patients with reflux disease and healthy controls","volume":"11","author":"P J Boekema","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"07","key":"ref116","first-page":"782","article-title":"A comparison of high and low fat meals on postprandial esophageal acid exposure","volume":"84","author":"D J Becker","year":"1989","journal-title":"Am J Gastroenterol"},{"issue":"06","key":"ref117","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1046\/j.1365-2036.1999.00528.x","article-title":"Lack of effect of spearmint on lower oesophageal sphincter function and acid reflux in healthy volunteers","volume":"13","author":"R Bulat","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"issue":"01","key":"ref118","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ccm.2014.11.001","article-title":"Medications and monitoring in nontuberculous mycobacteria infections","volume":"36","author":"E F Egelund","year":"2015","journal-title":"Clin Chest Med"},{"issue":"01","key":"ref119","doi-asserted-by":"crossref","first-page":"TNM17","DOI":"10.1128\/microbiolspec.TNMI7-0029-2016","article-title":"The role of therapeutic drug monitoring in mycobacterial infections","volume":"5","author":"C Peloquin","year":"2017","journal-title":"Microbiol Spectr"},{"issue":"06","key":"ref120","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1164\/rccm.201503-0444OC","article-title":"Semiquantitative culture analysis during therapy for Mycobacterium avium complex lung disease","volume":"192","author":"D E Griffith","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/1471-2164-15-359","article-title":"Genome analysis reveals three genomospecies in Mycobacterium abscessus","volume":"15","author":"M Sassi","year":"2014","journal-title":"BMC Genomics"},{"issue":"09","key":"ref122","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1164\/rccm.200905-0704OC","article-title":"Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients","volume":"180","author":"K Jeon","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"07","key":"ref123","first-page":"1945","article-title":"Differential antibiotic susceptibility of Mycobacterium abscessus variants in biofilms and macrophages compared to that of planktonic bacteria","volume":"69","author":"R Greendyke","year":"2014","journal-title":"Antimicrob Chemother"},{"issue":"04","key":"ref124","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijantimicag.2009.12.008","article-title":"High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria","volume":"35","author":"G-H Shen","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"ref125","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1128\/AAC.01505-12","article-title":"In vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial disease","volume":"56","author":"J van Ingen","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"07","key":"ref126","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1128\/AAC.40.7.1676","article-title":"Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus","volume":"40","author":"R J Wallace Jr","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"02","key":"ref127","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jac\/dkh523","article-title":"Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum","volume":"55","author":"K A Nash","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"04","key":"ref128","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1128\/AAC.01275-08","article-title":"A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae","volume":"53","author":"K A Nash","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"09","key":"ref129","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1164\/rccm.201111-2005OC","article-title":"Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance","volume":"186","author":"G-E Choi","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"ref130","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1128\/JCM.01175-12","article-title":"Clinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseases","volume":"50","author":"T Harada","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"01","key":"ref131","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ccm.2014.10.004","article-title":"The treatment of rapidly growing mycobacterial infections","volume":"36","author":"S H Kasperbauer","year":"2015","journal-title":"Clin Chest Med"},{"issue":"05","key":"ref132","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1164\/ajrccm\/147.5.1271","article-title":"Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients","volume":"147","author":"D E Griffith","year":"1993","journal-title":"Am Rev Respir Dis"},{"issue":"05","key":"ref133","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/cid\/ciq237","article-title":"Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease","volume":"52","author":"J Jarand","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"01","key":"ref134","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ccm.2014.11.004","article-title":"Surgical approach to pulmonary nontuberculous mycobacterial infections","volume":"36","author":"J D Mitchell","year":"2015","journal-title":"Clin Chest Med"},{"issue":"01","key":"ref135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1128\/JCM.02260-12","article-title":"Comparative drug resistance of Mycobacterium abscessus and M. chelonae isolates from patients with and without cystic fibrosis in the United Kingdom","volume":"51","author":"A Broda","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"06","key":"ref136","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1128\/AAC.28.6.807","article-title":"Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae","volume":"28","author":"J M Swenson","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"issue":"04","key":"ref137","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1128\/AAC.24.4.486","article-title":"Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics","volume":"24","author":"M S Stone","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"issue":"04","key":"ref138","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/AAC.35.4.773","article-title":"Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid","volume":"35","author":"R J Wallace Jr","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"issue":"01","key":"ref139","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1148\/radiol.12111374","article-title":"Serial CT findings of Mycobacterium massiliense pulmonary disease compared with Mycobacterium abscessus disease after treatment with antibiotic therapy","volume":"263","author":"H S Kim","year":"2012","journal-title":"Radiology"},{"key":"ref140","first-page":"43","article-title":"Successful use of linezolid for refractory Mycobacterium abscessus infection: a case report","volume":"23","author":"T Inoue","year":"2017","journal-title":"Respir Med Case Rep"},{"issue":"03","key":"ref141","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/AAC.45.3.764-767.2001","article-title":"Activities of linezolid against rapidly growing mycobacteria","volume":"45","author":"R J Wallace Jr","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"06","key":"ref142","first-page":"606","article-title":"Linezolid for the treatment of patients with [corrected] mycobacterial infections [corrected] a systematic review","volume":"11","author":"F Ntziora","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"issue":"04","key":"ref143","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1183\/09031936.00169114","article-title":"The tolerability of linezolid in the treatment of nontuberculous mycobacterial disease","volume":"45","author":"K L Winthrop","year":"2015","journal-title":"Eur Respir J"},{"issue":"06","key":"ref144","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1128\/JCM.00274-17","article-title":"In vitro susceptibility testing of Tedizolid against nontuberculous mycobacteria","volume":"55","author":"B A Brown-Elliott","year":"2017","journal-title":"J Clin Microbiol"},{"issue":"04","key":"ref145","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1517\/13543784.2012.660250","article-title":"Tedizolid (TR-701): a new oxazolidinone with enhanced potency","volume":"21","author":"Z A Kanafani","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"issue":"07","key":"ref146","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/jac\/dku062","article-title":"Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections","volume":"69","author":"R J Wallace Jr","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"06","key":"ref147","doi-asserted-by":"crossref","first-page":"e00470","DOI":"10.1128\/AAC.00470-19","article-title":"In vitro activity of new tetracycline analogs Omadacycline and Eravacycline against drug-resistant clinical isolates of Mycobacterium abscessus","volume":"63","author":"A Kaushik","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"09","key":"ref148","doi-asserted-by":"crossref","first-page":"e01135","DOI":"10.1128\/AAC.01135-17","article-title":"Comparison of omadacycline and tigecycline pharmacokinetics in the plasma, epithelial lining fluid, and alveolar cells of healthy subjects","volume":"61","author":"M H Gotfried","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"05","key":"ref149","doi-asserted-by":"crossref","first-page":"e02522","DOI":"10.1128\/AAC.02522-18","article-title":"In vitro activities of omadacycline against rapidly growing mycobacteria","volume":"63","author":"C Shoen","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"04","key":"ref150","doi-asserted-by":"crossref","first-page":"e02613","DOI":"10.1128\/AAC.02613-18","article-title":"Select \u03b2-lactam combinations exhibit synergy against Mycobacterium abscessus in vitro","volume":"63","author":"E Story-Roller","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"01","key":"ref151","doi-asserted-by":"crossref","first-page":"e02895","DOI":"10.1128\/mBio.02895-18","article-title":"Dual \u03b2-lactam combinations highly active against Mycobacterium abscessus complex in vitro","volume":"10","author":"R Pandey","year":"2019","journal-title":"MBio"},{"issue":"05","key":"ref152","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","article-title":"Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus","volume":"25","author":"R M Dedrick","year":"2019","journal-title":"Nat Med"},{"issue":"02","key":"ref153","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jcf.2019.05.002","article-title":"Pilot study to test inhaled nitric oxide in cystic fibrosis patients with refractory Mycobacterium abscessus lung infection","volume":"19","author":"B Lea","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"04","key":"ref154","doi-asserted-by":"crossref","first-page":"1702127","DOI":"10.1183\/13993003.02127-2017","article-title":"Inhaled granulocyte-macrophage colony-stimulating factor for Mycobacterium abscessus in cystic fibrosis","volume":"51","author":"J P Scott","year":"2018","journal-title":"Eur Respir J"},{"issue":"11","key":"ref155","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1099\/ijsem.0.003026","article-title":"A definition of the Mycobacterium avium complex for taxonomical and clinical purposes, a review","volume":"68","author":"J van Ingen","year":"2018","journal-title":"Int J Syst Evol Microbiol"},{"issue":"06","key":"ref156","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1378\/chest.12-0494","article-title":"Clinical significance of the differentiation between Mycobacterium avium and Mycobacterium intracellulare in M. avium complex lung disease","volume":"142","author":"W J Koh","year":"2012","journal-title":"Chest"},{"issue":"01","key":"ref157","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1378\/chest.102.1.89","article-title":"Comparison of prognosis of pulmonary diseases caused by Mycobacterium avium and by Mycobacterium intracellulare","volume":"102","author":"S Yamori","year":"1992","journal-title":"Chest"},{"issue":"05","key":"ref158","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1378\/chest.104.5.1408","article-title":"A clinical comparison between Mycobacterium avium and Mycobacterium intracellulare infections","volume":"104","author":"S Maesaki","year":"1993","journal-title":"Chest"},{"issue":"01","key":"ref159","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/IAI.00257-09","article-title":"Mannose receptor-dependent delay in phagosome maturation by Mycobacterium avium glycopeptidolipids","volume":"78","author":"L Sweet","year":"2010","journal-title":"Infect Immun"},{"issue":"01","key":"ref160","first-page":"9","article-title":"Effect of serotype specific glycopeptidolipid (GPL) isolated from Mycobacterium avium complex (MAC) on phagocytosis and phagosome-lysosome fusion of human peripheral blood monocytes","volume":"75","author":"Y Takegaki","year":"2000","journal-title":"Kekkaku"},{"issue":"02","key":"ref161","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1128\/CMR.00036-06","article-title":"Mycobacterium avium in the postgenomic era","volume":"20","author":"C Y Turenne","year":"2007","journal-title":"Clin Microbiol Rev"},{"issue":"01","key":"ref162","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/AEM.72.1.819-825.2006","article-title":"Mycobacterium avium genes associated with the ability to form a biofilm","volume":"72","author":"Y Yamazaki","year":"2006","journal-title":"Appl Environ Microbiol"},{"issue":"14","key":"ref163","doi-asserted-by":"crossref","first-page":"10517","DOI":"10.1016\/S0021-9258(18)82229-3","article-title":"Rough morphological variants of Mycobacterium avium. Characterization of genomic deletions resulting in the loss of glycopeptidolipid expression","volume":"268","author":"J T Belisle","year":"1993","journal-title":"J Biol Chem"},{"issue":"03","key":"ref164","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5588\/ijtld.11.0148","article-title":"Predictors of 5-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease","volume":"16","author":"Y Ito","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"issue":"02","key":"ref165","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1378\/chest.13-2538","article-title":"Macrolide\/Azalide therapy for nodular\/bronchiectatic mycobacterium avium complex lung disease","volume":"146","author":"R J Wallace Jr","year":"2014","journal-title":"Chest"},{"key":"ref166","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1164\/ajrccm.153.6.8665032","article-title":"Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients","volume":"153","author":"R J Wallace Jr","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"03","key":"ref167","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1164\/ajrccm.160.3.9811086","article-title":"Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease","volume":"160","author":"E Tanaka","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"08","key":"ref168","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1164\/rccm.200603-450OC","article-title":"Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease","volume":"174","author":"D E Griffith","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"04","key":"ref169","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.mcna.2011.03.012","article-title":"Review of macrolides (azithromycin, clarithromycin), ketolids (telithromycin) and glycylcyclines (tigecycline)","volume":"95","author":"J M Zuckerman","year":"2011","journal-title":"Med Clin North Am"},{"issue":"01","key":"ref170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1513\/AnnalsATS.201308-266OC","article-title":"Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study","volume":"11","author":"S Miwa","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"11","key":"ref171","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/420742","article-title":"Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases","volume":"38","author":"C A Peloquin","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"03","key":"ref172","doi-asserted-by":"crossref","first-page":"1602503","DOI":"10.1183\/13993003.02503-2016","article-title":"Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype","volume":"50","author":"W J Koh","year":"2017","journal-title":"Eur Respir J"},{"issue":"06","key":"ref173","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1128\/AAC.04577-14","article-title":"Risk factors for recurrence after successful treatment of Mycobacterium avium complex lung disease","volume":"59","author":"B Y Lee","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"07","key":"ref174","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/cid\/cix517","article-title":"Treatment outcomes of Mycobacterium avium complex lung disease: a systematic review and meta-analysis","volume":"65","author":"N Kwak","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"08","key":"ref175","doi-asserted-by":"crossref","first-page":"e008058","DOI":"10.1136\/bmjopen-2015-008058","article-title":"Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular\/bronchiectatic Mycobacterium avium complex lung disease","volume":"5","author":"M Gochi","year":"2015","journal-title":"BMJ Open"},{"issue":"11","key":"ref176","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1128\/AAC.01240-16","article-title":"Clinical characteristics, treatment outcomes, and resistance mutations associated with macrolide-resistant Mycobacterium avium complex lung disease","volume":"60","author":"S M Moon","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"ref177","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1513\/AnnalsATS.201604-246OC","article-title":"Macrolide-resistant Mycobacterium avium complex lung disease: analysis of 102 consecutive cases","volume":"13","author":"K Morimoto","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"03","key":"ref178","doi-asserted-by":"crossref","first-page":"1800170","DOI":"10.1183\/13993003.00170-2018","article-title":"Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement","volume":"51","author":"J van Ingen","year":"2018","journal-title":"Eur Respir J"},{"issue":"05","key":"ref179","doi-asserted-by":"crossref","first-page":"1801636","DOI":"10.1183\/13993003.01636-2018","article-title":"Unresolved issues in treatment outcome definitions for nontuberculous mycobacterial pulmonary disease","volume":"53","author":"S M Moon","year":"2019","journal-title":"Eur Respir J"},{"issue":"06","key":"ref180","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1164\/rccm.201604-0700OC","article-title":"Randomized trial of liposomal amikacin for inhalation in nontuberculous mycobacterial lung disease","volume":"195","author":"K N Olivier","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"ref181","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1164\/rccm.201807-1318OC","article-title":"Amikacin liposome inhalation suspension for treatment-refractory lung disease caused by Mycobacterium avium complex (CONVERT): a prospective, open-label, randomized study","volume":"198","author":"D E Griffith","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"09","key":"ref182","doi-asserted-by":"crossref","first-page":"e108703","DOI":"10.1371\/journal.pone.0108703","article-title":"Delivery of aerosolized liposomal amikacin as a novel approach for the treatment of nontuberculous mycobacteria in an experimental model of pulmonary infection","volume":"9","author":"S J Rose","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"ref183","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.1128\/AAC.00700-16","article-title":"Pulmonary deposition and elimination of liposomal amikacin for inhalation and effect on macrophage function after administration in rats","volume":"60","author":"V Malinin","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"ref184","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3389\/fmicb.2018.00915","article-title":"Amikacin liposome inhalation suspension (ALIS) penetrates non-tuberculous mycobacterial biofilms and enhances amikacin uptake into macrophages","volume":"9","author":"J Zhang","year":"2018","journal-title":"Front Microbiol"},{"issue":"03","key":"ref185","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1128\/AAC.40.3.633","article-title":"Antituberculosis activities of clofazimine and its new analogs B4154 and B4157","volume":"40","author":"V M Reddy","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"05","key":"ref186","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1378\/chest.15-0543","article-title":"Long-term follow-up of Mycobacterium avium complex lung disease in patients treated with regimens including Clofazimine and\/or Rifampin","volume":"149","author":"J Jarand","year":"2016","journal-title":"Chest"},{"issue":"04","key":"ref187","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chest.2017.04.175","article-title":"Safety and effectiveness of Clofazimine for primary and refractory nontuberculous mycobacterial infection","volume":"152","author":"S L Martiniano","year":"2017","journal-title":"Chest"},{"issue":"08","key":"ref188","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s40265-014-0222-8","article-title":"Therapeutic drug monitoring in the treatment of tuberculosis: an update","volume":"74","author":"A Alsultan","year":"2014","journal-title":"Drugs"},{"issue":"05","key":"ref189","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/106002809102500513","article-title":"Clofazimine: a review of its use in leprosy and Mycobacterium avium complex infection","volume":"25","author":"J C Garrelts","year":"1991","journal-title":"DICP"},{"issue":"06","key":"ref190","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2217\/fmb.10.50","article-title":"TMC207: the first compound of a new class of potent anti-tuberculosis drugs","volume":"5","author":"A Matteelli","year":"2010","journal-title":"Future Microbiol"},{"issue":"05","key":"ref191","doi-asserted-by":"crossref","first-page":"e02627","DOI":"10.1128\/AAC.02627-16","article-title":"In vitro activity of Bedaquiline against nontuberculous mycobacteria in China","volume":"61","author":"Y Pang","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"02","key":"ref192","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1378\/chest.14-2764","article-title":"Preliminary results of Bedaquiline as salvage therapy for patients with nontuberculous mycobacterial lung disease","volume":"148","author":"J V Philley","year":"2015","journal-title":"Chest"},{"issue":"04","key":"ref193","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0003-4975(10)60065-3","article-title":"Elective pulmonary lobectomy: factors associated with morbidity and operative mortality","volume":"40","author":"B A Keagy","year":"1985","journal-title":"Ann Thorac Surg"},{"issue":"04","key":"ref194","first-page":"379","article-title":"Pulmonary function evaluation of the lung resection candidate: a prospective study","volume":"111","author":"G N Olsen","year":"1975","journal-title":"Am Rev Respir Dis"},{"issue":"02","key":"ref195","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/thorax.56.2.89","article-title":"BTS guidelines: guidelines on the selection of patients with lung cancer for surgery","volume":"56","author":"P Armstrong","year":"2001","journal-title":"Thorax"},{"issue":"06","key":"ref196","first-page":"489","article-title":"Prognostic factors for complications following pulmonary resection: pre-albumin analysis, time on mechanical ventilation, and other factors","volume":"32","author":"R CG Bianchi","year":"2006","journal-title":"J Bras Pneumol"},{"issue":"01","key":"ref197","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.athoracsur.2016.05.057","article-title":"Operative risk for major lung resection increases at extremes of body mass index","volume":"103","author":"T Williams","year":"2017","journal-title":"Ann Thorac Surg"},{"issue":"01","key":"ref198","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jtcvs.2009.03.030","article-title":"Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancer","volume":"138","author":"R M Flores","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"02","key":"ref199","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jtcvs.2009.04.026","article-title":"Thoracoscopic lobectomy is associated with lower morbidity compared with thoracotomy","volume":"138","author":"N R Villamizar","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"06","key":"ref200","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.athoracsur.2008.07.009","article-title":"Surgery for early-stage non-small cell lung cancer: a systematic review of the video-assisted thoracoscopic surgery versus thoracotomy approaches to lobectomy","volume":"86","author":"B A Whitson","year":"2008","journal-title":"Ann Thorac Surg"},{"issue":"02","key":"ref201","doi-asserted-by":"crossref","first-page":"S719","DOI":"10.1016\/j.athoracsur.2007.09.056","article-title":"Is video-assisted thoracic surgery lobectomy better? Quality of life considerations","volume":"85","author":"T L Demmy","year":"2008","journal-title":"Ann Thorac Surg"},{"issue":"01","key":"ref202","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4103\/0972-9941.147693","article-title":"Robotic thoracic surgery: the state of the art","volume":"11","author":"A Kumar","year":"2015","journal-title":"J Minim Access Surg"},{"key":"ref203","first-page":"1096","article-title":"An operation for tuberculous empyema","volume":"60","author":"L Eloesser","year":"1935","journal-title":"Surg Gynecol Obstet"},{"issue":"05","key":"ref204","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/clinids\/3.5.1064","article-title":"Surgical management of pulmonary disease due to Mycobacterium avium-intracellulare","volume":"3","author":"R F Corpe","year":"1981","journal-title":"Rev Infect Dis"},{"issue":"02","key":"ref205","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0003-4975(98)00401-9","article-title":"Results of operation in Mycobacterium avium-intracellulare lung disease","volume":"66","author":"K G Nelson","year":"1998","journal-title":"Ann Thorac Surg"},{"issue":"06","key":"ref206","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/j.athoracsur.2006.01.031","article-title":"Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones","volume":"81","author":"M Watanabe","year":"2006","journal-title":"Ann Thorac Surg"},{"issue":"06","key":"ref207","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.athoracsur.2008.02.041","article-title":"Anatomic lung resection for nontuberculous mycobacterial disease","volume":"85","author":"J D Mitchell","year":"2008","journal-title":"Ann Thorac Surg"},{"issue":"03","key":"ref208","first-page":"671","article-title":"Lady Windermere revisited: treatment with thoracoscopic lobectomy\/segmentectomy for right middle lobe and lingular bronchiectasis associated with non-tuberculous mycobacterial disease","volume":"40","author":"J A Yu","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"issue":"01","key":"ref209","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.athoracsur.2013.03.008","article-title":"Adjuvant surgical treatment of nontuberculous mycobacterial lung disease","volume":"96","author":"Y Shiraishi","year":"2013","journal-title":"Ann Thorac Surg"},{"issue":"02","key":"ref210","doi-asserted-by":"crossref","first-page":"954","DOI":"10.21037\/jtd.2018.01.60","article-title":"The outcomes of anatomical lung resection for nontuberculous mycobacterial lung disease","volume":"10","author":"T Sakane","year":"2018","journal-title":"J Thorac Dis"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1730997.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T18:45:50Z","timestamp":1626288350000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1730997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,14]]},"references-count":208,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2021,7,14]]},"published-print":{"date-parts":[[2021,8]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1730997","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,14]]}}}